Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.

@article{Eichenfield2010Adapalene0L,
  title={Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.},
  author={Lawrence F Eichenfield and Michael M Jarratt and Joel Schlessinger and Steven Kempers and Vasant Manna and Joyce J. Hwa and Yin Liu and Michael Graeber},
  journal={Journal of drugs in dermatology : JDD},
  year={2010},
  volume={9 6},
  pages={639-46}
}
BACKGROUND Acne vulgaris is a common chronic skin disease affecting roughly 15 percent of the general population and up to 85 percent of adolescents and young adults. Adapalene, a synthetic naphthoic acid derivative with retinoid activity, has demonstrated good clinical efficacy in the treatment of acne if used with full compliance. OBJECTIVES To evaluate… CONTINUE READING